NL-OMON27188暂停不适用
Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid Leukaemia.
VU University medical center0 个研究点目标入组 31 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 31
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with Acute Myeloid Leukemia according to WHO classification 2008;
- •2. Age 18-75;
排除标准
- •1. Myelodysplastic syndrome with refractory anaemia with excess blasts (RAEB);
- •2. Acute Promyelocytic Leukemia (AML M3);
研究者
相似试验
已完成
不适用
Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid Leukaemiaacute myeloid leukemia10024324AMLNL-OMON38951Vrije Universiteit Medisch Centrum31
进行中（未招募）
不适用
Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid LeukaemiaMinimal residual disease after allogeneic stem cell transplantation in Acute Myeloid LeukaemiaMedDRA version: 15.1Level: LLTClassification code 10001941Term: AMLSystem Organ Class: 100000004864EUCTR2013-000238-37-NLVU University medical center
招募中
2 期
Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsMultiple MyelomaNCT05231629University of Alabama at Birmingham300
招募中
3 期
Randomized clinical study to evaluate utility of response adapted treatment in patients with newly diagnosed multiple myelomaCTRI/2021/11/037702Intramural grant of Tata Memorial Center Mumbai
Enrolling By Invitation
不适用
GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIESPancreatic AdenocarcinomaNCT06102889Karolinska University Hospital200